Immuno Oncology Talks

Targeting Neutrophils as effector cells in cancer therapy

13 joulukuun, 2022


 Marjolein van Egmond

The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in cancer therapy. Professor Marjolein van Egmond specializes in the innate immune system and is focusing on elucidating the therapeutic potential of neutrophils in cancer, with a specific interest in IgA and bispecific antibodies to activate the neutrophils.

For more information please visit:
Sanofi Immuno Oncology Talks website

Share this podcast with your colleagues

MAT-BE-2200978 (ver. 1.0) 12 2022